COVID-19 Registry Aims To Map And Address Potential Test Shortages
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
You may also be interested in...
FDA Authorizes Abbott’s '$5, 15 Minute' COVID-19 Antigen Test
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
Diagnostics Makers Aim To Produce 25 Million COVID-19 Tests By End Of April
The head of the largest medical device lobby group told reporters the industry hopes to get 25 million diagnostic tests produced by the end of the month to fight the ongoing coronavirus pandemic in the US.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.